申请人:Adir et Compagnie
公开号:US05130301A1
公开(公告)日:1992-07-14
Novel 4H-pyrrolo[1,2-a]thieno[2,3-f][1,4]diazepine which are usable as a medicinal product and correspond to the general formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and R.sub.4 have the same meaning as given in the specification. These compounds, as well as their physiologically tolerable salts, may be used in therapy, in particular in the treatment of disorders linked to hypoxemia and to certain metabolic disorders.
可用作药物的新型4H-吡咯并[1,2-a]噻吩[2,3-f][1,4]二氮杂环庚烷,符合一般式(I):##STR1## 其中:R.sub.1、R.sub.2、R.sub.3和R.sub.4的含义与说明书中给出的相同。这些化合物及其生理耐受盐可用于治疗,特别是用于治疗与缺氧和某些代谢紊乱相关的疾病。